Oramed Pharmaceuticals Files 8-K: Other Event
Ticker: ORMP · Form: 8-K · Filed: Mar 19, 2024 · CIK: 1176309
| Field | Detail |
|---|---|
| Company | Oramed Pharmaceuticals Inc. (ORMP) |
| Form Type | 8-K |
| Filed Date | Mar 19, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.012, $101,875,000, $5 million, $15 million, $11.5 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: other-event, filing-update
Related Tickers: ORMP
TL;DR
ORMP filed an 8-K for an 'Other Event' on 3/14. Details TBD.
AI Summary
On March 14, 2024, Oramed Pharmaceuticals Inc. filed an 8-K report detailing an "Other Event." The filing does not provide specific details about the event itself, but it was submitted on March 19, 2024, with the earliest reported event date being March 14, 2024. The company's principal executive offices are located at 1185 Avenue of the Americas, New York, NY.
Why It Matters
This filing indicates a material event has occurred for Oramed Pharmaceuticals, requiring disclosure to investors. The lack of detail in the filing itself necessitates further investigation to understand the event's implications.
Risk Assessment
Risk Level: medium — The filing indicates a material event has occurred, but the lack of specific details creates uncertainty and potential risk for investors.
Key Players & Entities
- ORAMED PHARMACEUTICALS INC. (company) — Registrant
- March 14, 2024 (date) — Earliest event reported
- March 19, 2024 (date) — Filing date
- 1185 Avenue of the Americas, Third Floor, New York, New York 10036 (location) — Principal Executive Offices
FAQ
What specific event is reported in this 8-K filing by Oramed Pharmaceuticals Inc.?
The filing is categorized under 'Other Events' and does not provide specific details about the nature of the event.
When was the earliest event reported in this filing?
The earliest event reported was on March 14, 2024.
On what date was this 8-K filing submitted to the SEC?
The filing was submitted on March 19, 2024.
Where are Oramed Pharmaceuticals Inc.'s principal executive offices located?
The principal executive offices are located at 1185 Avenue of the Americas, Third Floor, New York, New York 10036.
What is the Commission File Number for Oramed Pharmaceuticals Inc.?
The Commission File Number for Oramed Pharmaceuticals Inc. is 001-35813.
Filing Stats: 845 words · 3 min read · ~3 pages · Grade level 13.9 · Accepted 2024-03-19 08:00:39
Key Financial Figures
- $0.012 — ch registered Common Stock, par value $0.012 ORMP The Nasdaq Capital Market, Te
- $101,875,000 — of issuance in the principal amount of $101,875,000 (the "Note"), as well as certain warran
- $5 million — received the first principal payment of $5 million on December 21, 2023. Pursuant to the t
- $15 million — e Note, the second principal payment of $15 million is due on March 21, 2024. On March 14,
- $11.5 million — he Company received an early payment of $11.5 million and on March 18, 2024, an early payment
- $3.5 million — on March 18, 2024, an early payment of $3.5 million. The third principal payment in the am
- $20 million — hird principal payment in the amount of $20 million is expected to be paid on June 21, 2024
Filing Documents
- ea0202046-8k_oramed.htm (8-K) — 25KB
- 0001213900-24-023721.txt ( ) — 194KB
- ormp-20240314.xsd (EX-101.SCH) — 3KB
- ormp-20240314_lab.xml (EX-101.LAB) — 33KB
- ormp-20240314_pre.xml (EX-101.PRE) — 22KB
- ea0202046-8k_oramed_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORAMED PHARMACEUTICALS INC. By: /s/ Nadav Kidron Name: Nadav Kidron Title: President and CEO March 19, 2024 2